Arsenic-exposed Keratinocytes Exhibit Differential MicroRNAs Expression Profile; Potential Implication of MiR-21, MiR-200a and MiR-141 in Melanoma Pathway
Overview
Authors
Affiliations
Long-term exposure to arsenic has been linked to cancer in different organs and tissues, including skin. Here, non-malignant human keratinocytes (HaCaT) were exposed to arsenic and its effects on microRNAs (miRNAs; miR) expression were analyzed miRCURY LNA array analyses. A total of 30 miRNAs were found differentially expressed in arsenic-treated cells, as compared to untreated controls. Among the up-regulated miRNAs, miR-21, miR-200a and miR-141, are well known to be involved in carcinogenesis. Additional findings confirmed that those three miRNAs were indeed up-regulated in arsenic-stimulated keratinocytes as demonstrated by quantitative PCR assay. Furthermore, bioinformatics analysis of both potential cancer-related pathways and targeted genes affected by miR-21, miR-200a and/or miR-141 was performed. Results revealed that miR-21, miR-200a and miR-141 are implicated in skin carcinogenesis related with melanoma development. Conclusively, our results indicate that arsenic-treated keratinocytes exhibited alteration in the miRNAs expression profile and that miR-21, miR-200a and miR-141 could be promising early biomarkers of the epithelial phenotype of cancer cells and they could be potential novel targets for melanoma therapeutic interventions.
Li Y, Zhao Q, Yao J, Lv C, Gao Y, Sun D Toxics. 2023; 11(12).
PMID: 38133379 PMC: 10747408. DOI: 10.3390/toxics11120978.
Epigenomic reprogramming in iAs-mediated carcinogenesis.
George S, Cassidy R, Saintilnord W, Fondufe-Mittendorf Y Adv Pharmacol. 2023; 96:319-365.
PMID: 36858778 PMC: 10860658. DOI: 10.1016/bs.apha.2022.08.004.
miRNAs and arsenic-induced carcinogenesis.
Nail A, Ferragut Cardoso A, Montero L, States J Adv Pharmacol. 2023; 96:203-240.
PMID: 36858773 PMC: 10184182. DOI: 10.1016/bs.apha.2022.10.002.
Arsenic and cancer: Evidence and mechanisms.
Speer R, Zhou X, Volk L, Liu K, Hudson L Adv Pharmacol. 2023; 96:151-202.
PMID: 36858772 PMC: 10860672. DOI: 10.1016/bs.apha.2022.08.001.
Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis.
Islam R, Zhao L, Wang Y, Lu-Yao G, Liu L Cancers (Basel). 2022; 14(18).
PMID: 36139662 PMC: 9496897. DOI: 10.3390/cancers14184502.